Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 25 Feb 2025

Fenvalerate exposure induces AKT/AMPK-dependent alterations in glucose metabolism in hepatoma cells

in Pharmacology of Anti-Cancer Drugs

Lu Sun
Zheng-Guo Cui
Qianwen Feng
Jibran Sualeh Muhammad
Yu-Jie Jin
Songji Zhao
Lingqi Zhou
Cheng-AI Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540567

1,355 views

Original Research

Published on 24 Feb 2025

Cepharanthine hydrochloride: a novel ferroptosis-inducing agent for prostate cancer treatment

in Pharmacology of Anti-Cancer Drugs

Jing-Song Guan
Jing Jia
Ze-Xiu Huang
Yu-Qing Zhou
Jing-Jie Zheng
Qi-Man Lin
Yi-Fei Wang
Jiang-Lin Fan
Yao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536375

1,951 views
1 citation

Review

Published on 24 Feb 2025

Asiatic acid in anticancer effects: emerging roles and mechanisms

in Pharmacology of Anti-Cancer Drugs

Rong Chen
Wan Zhang
Meizhi Zhang
Weidong Liu
Weike Feng
Yanan Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1545654

1,152 views

Original Research

Published on 24 Feb 2025

Gold complex QB1561 suppresses drug-resistant cancer cells by inhibiting TrxR and mitochondrial respiratory function

in Pharmacology of Anti-Cancer Drugs

Hai-Ling Gao
Wenwen Ding
Zhi-Xin Shen
Qingbin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1560880

1,602 views

Mini Review

Published on 21 Feb 2025

Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives

in Pharmacology of Anti-Cancer Drugs

Xianglong Shi
Kai Tang
Quanbin Zhang
Qingkun Han
Lin Quan
Yijing Li
Jianqiao Cui
Nuan Feng
Jianbao Gong
Baoxin Shang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1556245

3,309 views
2 citations

Review

Published on 21 Feb 2025

A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas

in Pharmacology of Anti-Cancer Drugs

A. Torchia
S. Vari
C. E. Onesti
S. Ceddia
M. Maschio
G. Maggi
F. Riva
W. Faltyn
M. Russillo
V. Ferraresi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1512966

1,808 views

Original Research

Published on 21 Feb 2025

Elucidation of Callistemon lanceolatus-derived natural compounds in STAT 3 pathway against human cancer cells: in silico and in vitro studies

in Pharmacology of Anti-Cancer Drugs

Mubashir Zafar
Sadaf Anwar
Malik Asif Hussain
Naveed Iqbal
Abrar Ali
Sadaf
Mohammad Zeeshan Najm
Mohd Adnan Kausar

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507002

879 views

Original Research

Published on 21 Feb 2025

Adverse drug reactions to atezolizumab in combination with bevacizumab in hepatocellular carcinoma patients: an analysis of the food and drug administration adverse event reporting system database

in Pharmacology of Anti-Cancer Drugs

Wanming He
Lihua Tong
Yanling Yuan
Xia Yang
Wen Yang
Xingxi Pan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1448095

1,851 views

Review

Published on 20 Feb 2025

Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies

in Pharmacology of Anti-Cancer Drugs

Jun Wen
Aiwen Li
Ziliang Wang
Xiaoxiao Guo
Gaoling Zhang
Mark R. Litzow
Qiuju Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1536388

1,306 views

Review

Published on 20 Feb 2025

Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived Dimethylaminomicheliolide and Micheliolide

in Pharmacology of Anti-Cancer Drugs

Jian Li
Xin Li
Hongwei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551115

935 views

Original Research

Published on 20 Feb 2025

β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1

in Pharmacology of Anti-Cancer Drugs

Pan Du
Yue Li
Anna Han
Mengying Wang
Jiajing Liu
Yingshi Piao
Liyan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1509568

1,283 views
1 citation

Case Report

Published on 20 Feb 2025

Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report

in Pharmacology of Anti-Cancer Drugs

Jianxin Chen
Jian Wang
Qinhong Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1431422

881 views

Original Research

Published on 19 Feb 2025

Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies

in Pharmacology of Anti-Cancer Drugs

Yuying Jiang
Yuance Xu
Junqi He
Lei Sui
Tian Li
Nannan Xia
Qin Yao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525733

1,844 views

Case Report

Published on 19 Feb 2025

Case report: Pharmacokinetic interaction involving sirolimus and regorafenib in patients with post-transplant recurrent hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Kongcai Zhu
Fang Xiong
Haihong Bai
Wei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1472896

735 views
1 citation

Original Research

Published on 19 Feb 2025

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction

in Pharmacology of Anti-Cancer Drugs

Ning Wang
Yinan Li
Yaoyao Wang
Wenting Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1540477

1,209 views

Original Research

Published on 19 Feb 2025

Dual inhibitor of MDM2 and NFAT1 for experimental therapy of breast cancer: in vitro and in vivo anticancer activities and newly discovered effects on cancer metabolic pathways

in Pharmacology of Anti-Cancer Drugs

Wei Wang
Marlene Aguilar
Sayantap Datta
Abigail Alley
Meheret Tadesse
Xinshi Wang
Xia Gao
Ruiwen Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1531667

1,618 views